Please login to the form below

Not currently logged in
Email:
Password:

EMG appoints Merck and Boehringer directors as new officers

David Garmon-Jones is new chair and Zinta Krumins is vice chair

edit-EMG-appoints-chairsUK trade body the European Medicines Group (EMG) has elected David Garmon-Jones, UK managing director of Merck Sereno, as its new chair and Zinta Krumins, UK managing director of Boehringer Ingelheim, as vice chair.

Garmon-Jones (left) was previously vice chair at the organisation, which provide a voice on UK health policy for 17 European companies based outside the country. He takes over from Steve Oldfield, former managing director for Sanofi UK.

Garmon-Jones has been with Merck Serono since 1983 and has served as managing director for the company's operations in the UK and Ireland since July 2012.

Commenting on his appointment as chair of the EMG, he said: “With the growing focus on the European Union and the future shape of the UK's relationship with Europe generally, EMG's views on the UK pharmaceutical industry's place within this becomes even more relevant.”

Krumins (right) joined Boehringer in 1989 and has held a variety of senior roles around the world including managing director for Turkey and the Nordics. She has also held leadership positions in corporate departments including head of corporate development and emerging markets area manager.

She has been managing director for Boehringer in the UK and Ireland since January 2014.

Krumins said: “Having spent the past seventeen years outside the UK in various different countries, I am delighted to have the opportunity of the officer role in the EMG, where the direct engagement with peers and other stakeholders will help to strengthen the position of my own organisation in meeting the changing requirements of the NHS.”

EMG represents UK operations in 17 research-driven pharma companies including Bayer, Novo Nordisk and Roche.

10th October 2014

From: Sales, Marketing, Regulatory, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics